Product Information
LEUPROLIDE 2WK 14 MG/2.8 ML KT is a generic product labeled by VGYAAN Pharmaceuticals LLC, priced at $261.3184 per EA under NDC 72664061128. Its NADAC has been published 94 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the Leuprolide Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
VGYAAN Pharmaceuticals LLCNDC
72664061128
Classification
Generic
Dosage Form
KIT
Last Updated
1/21/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA213829On Market Since
10/25/2020
Price Statistics
The NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has been published 94 times since Apr 17, 2024, and over the history we have for it it has risen 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $261.3184 per EA |
|---|---|
| All-time high | $301.8717 (Sep 10, 2025) |
| All-time low | $217.5983 (Jul 17, 2024) |
| 52-week high | $301.8717 |
| 52-week low | $241.4400 |
| Median price | $264.5017 |
| Average price | $265.9443 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 94 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEUPROLIDE 2WK 14 MG/2.8 ML KT?
The current National Average Drug Acquisition Cost (NADAC) for LEUPROLIDE 2WK 14 MG/2.8 ML KT, manufactured by VGYAAN Pharmaceuticals LLC, is $261.3184 per EA (NDC 72664061128), effective Jan 28, 2026.
How has the price of LEUPROLIDE 2WK 14 MG/2.8 ML KT changed over time?
Over the history we have for it, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has risen 13.4%. It has been tracked across 94 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Since Apr 17, 2024, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has ranged from a low of $217.5983 (Jul 17, 2024) to a high of $301.8717 (Sep 10, 2025), with a median of $264.5017 per EA.
Are there cheaper alternatives to LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEUPROLIDE 2WK 14 MG/2.8 ML KT, is $197.6060 per EA — about 24% below LEUPROLIDE 2WK 14 MG/2.8 ML KT.
Who manufactures LEUPROLIDE 2WK 14 MG/2.8 ML KT?
LEUPROLIDE 2WK 14 MG/2.8 ML KT (NDC 72664061128) is labeled by VGYAAN Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification